• Platform
    • The SOPHiA DDM™ Platform
    • Genomics
    • Radiomics
    • Multimodal
    • Alamut Visual Plus™
    • OncoPortal™ Plus
    • SOPHiA Integrated Solutions
  • Solutions
    • Clinical
    • Oncology
    • Solid Tumors
    • Blood Cancers
    • Hereditary Cancers
    • Rare and Inherited Diseases
    • Cardiology
    • Neurological Disorders
    • Metabolism
    • Rare Diseases
    • BioPharma
  • Resources
    • Case Studies
    • Publications
    • Webinars
    • Science Hub
  • Company
    • About Us
    • Leadership Team
    • Investors
    • Press Releases
    • Press Kit
    • Blog
    • Events
    • Careers
    • Partner With Us
    • Contact Us
  • REQUEST A DEMO
SOPHiA GENETICS
SOPHiA GENETICS
  • Platform
    • The Sophia ddm platform
      • Genomics
      • Radiomics
      • Multimodal
    • .
      • Alamut Visual Plus™
      • OncoPortal™ Plus
      • SOPHiA Integrated Solutions
  • Solutions
    • Clinical
      • Oncology
        • Solid Tumors
        • Blood Cancers
        • Hereditary Cancers
    • .
      • Rare and Inherited Diseases
        • Cardiology
        • Metabolism
        • Neurological Disorders
        • Rare Diseases
    • BioPharma
      • Discover BioPharma
  • Resources
    • Case Studies
    • Publications
    • Webinars
    • Science Hub
  • Company
    • About SOPHiA GENETICS
      • About Us
      • Leadership Team
      • Investors
      • Press Releases
      • Press Kit
    • Useful Links
      • Blog
      • Events
      • Careers
      • Partner With Us
      • Contact Us
  • REQUEST A DEMO
  • Home
  • 5
  • Events

Events

Confirmation d’un syndrome de Kallmann par l’étude de la segregation

Confirmation d’un syndrome de Kallmann par l’étude de la segregation

read more
Advanced germline variant analysis with the SOPHiA Platform

Advanced germline variant analysis with the SOPHiA Platform

read more
Comprehensive Tumor Profiling Capabilities for Actionable Insights

Comprehensive Tumor Profiling Capabilities for Actionable Insights

read more
Overcoming Limitations of Assessing HRR Deficiency in Somatic Samples with NGS

Overcoming Limitations of Assessing HRR Deficiency in Somatic Samples with NGS

read more
Turn your Sequencing Lab into a COVID-19 Research and Surveillance Powerhouse

Turn your Sequencing Lab into a COVID-19 Research and Surveillance Powerhouse

read more
Ensuring high resolution CNV detection

Ensuring high resolution CNV detection

read more
Comprehensive Profiling of Myeloid Malignancies at Moffitt Cancer Center

Comprehensive Profiling of Myeloid Malignancies at Moffitt Cancer Center

read more
Our Co-Founder Lars Steinmetz at PMWC 2021 COVID: Tracking COVID-19 with a System Clinical Approach

Our Co-Founder Lars Steinmetz at PMWC 2021 COVID: Tracking COVID-19 with a System Clinical Approach

read more
Radiomics with AI: the key to Data-Driven Medicine in Oncology

Radiomics with AI: the key to Data-Driven Medicine in Oncology

read more
Robust CNV detection using Whole Exome Sequencing

Robust CNV detection using Whole Exome Sequencing

read more
SOPHiA DDM™ Platform and Microsoft Azure for Genomics: when Accuracy meets Security

SOPHiA DDM™ Platform and Microsoft Azure for Genomics: when Accuracy meets Security

read more
Garantizando la identificación de CNV de alta resolución

Garantizando la identificación de CNV de alta resolución

read more
« Older Entries
Next Entries »
logo footer
Platform

The SOPHiA DDM™ Platform
Genomics
Radiomics
Multimodal
Alamut Visual Plus™
OncoPortal™ Plus
SOPHiA Integrated Solutions

SOLUTIONS

Oncology
Rare and Inherited Diseases
Cardiology
Neurological Disorders
Metabolism
BioPharma

RESOURCES

Publications
Case Studies
Webinars
Science Hub

Company

About Us
Leadership Team
Investors
Press Releases
Press Kit
Blog

Company

Events
Careers
Partner With Us
Contact Us
Request A Demo

© 2021 SOPHiA GENETICS. All rights reserved. Privacy Policy | Terms of Use | Legal | Sitemap
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow

SOPHiA GENETICS products are for Research Use Only and not for use in diagnostic procedures unless specified otherwise.
SOPHiA Hereditary Cancer Solution, SOPHiA Myeloid Solution, SOPHiA Solid Tumor Solution are available as CE-IVD product for In Vitro Diagnostic Use in Europe, Turkey and Israel. Information about products which may or may not be available in different countries and if applicable, may or may not have received approval or market clearance by a governmental regulatory body for different indications for use. Please contact us at [email protected] to obtain the appropriate product information for your country of residence.

All third-party trademarks listed by SOPHiA GENETICS remain the property of their respective owners. Unless specifically identified as such, SOPHiA GENETICS’ use of third-party trademarks does not indicate any relationship, sponsorship, or endorsement between SOPHiA GENETICS and the owners of these trademarks. Any references by SOPHiA GENETICS to third-party trademarks is to identify the corresponding third-party goods and/or services and shall be considered nominative fair use under the trademark law.

Somatic gene variant annotations and related content have been powered by, without limitation, The Jackson Laboratory Clinical Knowledgebase (JAX-CKB™).

SOPHiA GENETICS
Platform

The SOPHiA DDM™ Platform
Genomics
Radiomics
Multimodal
Alamut Visual Plus™
OncoPortal™ Plus
SOPHiA Integrated Solutions

SOLUTIONS

Oncology
Rare and Inherited Diseases
Cardiology
Neurological Disorders
Metabolism
BioPharma

RESOURCES

Publications
Case Studies
Webinars
Science Hub

Company

About Us
Leadership Team
Investors
Press Releases
Press Kit
Blog
Events
Careers
Partner With Us
Contact Us
Request A Demo

© 2021 SOPHiA GENETICS. All rights reserved.
Privacy Policy | Terms of Use | Legal | Sitemap
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow

SOPHiA GENETICS products are for Research Use Only and not for use in diagnostic procedures unless specified otherwise.
SOPHiA Hereditary Cancer Solution, SOPHiA Myeloid Solution, SOPHiA Solid Tumor Solution are available as CE-IVD product for In Vitro Diagnostic Use in Europe, Turkey and Israel. Information about products which may or may not be available in different countries and if applicable, may or may not have received approval or market clearance by a governmental regulatory body for different indications for use. Please contact us at [email protected] to obtain the appropriate product information for your country of residence.

All third-party trademarks listed by SOPHiA GENETICS remain the property of their respective owners. Unless specifically identified as such, SOPHiA GENETICS’ use of third-party trademarks does not indicate any relationship, sponsorship, or endorsement between SOPHiA GENETICS and the owners of these trademarks. Any references by SOPHiA GENETICS to third-party trademarks is to identify the corresponding third-party goods and/or services and shall be considered nominative fair use under the trademark law.

Somatic gene variant annotations and related content have been powered by, without limitation, The Jackson Laboratory Clinical Knowledgebase (JAX-CKB™).